NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDCabozantinib Cabometyx®
(Tablets) 		Malignant disease and immunosuppression, Protein kinase inhibitors, 08.01.05
REDCabozantinib Cometriq®
(Capsules) 		Malignant disease and immunosuppression, Protein kinase inhibitors, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Cabozantinib Cabozantinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA463: Cabozantinib for previously treated advanced renal cell carcinoma
NICE TA516: Cabozantinib for treating medullary thyroid cancer
NICE TA542: Cabozantinib for untreated advanced renal cell carcinoma
NICE TA849: Cabozantinib for previously treated advanced hepatocellular carcinoma
NICE TA928: Cabozantinib for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodine (NOT RECOMMENDED)
NICE TA964: Cabozantinib with nivolumab for untreated advanced renal cell carcinoma